Develop capsule-based screening technology for medical diagnostics. Focus on non-invasive alternatives to traditional screening methods. Now — the numbers.
There is not enough trading history here to call this an established business.
Red columns mark years that ended in a loss.
If every debt were paid off today, $203K would still be left in the vault — a solid cushion for hard times.
The market pays 1.6× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
Against companies in its own sector, it looks cheaper than 83% of them.
No analyst target is on record for this company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
The price looks reasonable next to what the company earns.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
An investor who bought at the very peak is down 71% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $219K in the vault; even if every debt were paid off, $203K would remain.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 19/100. For a turnaround signal, the stock first needs to close the gap with the market.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 45/100.
As the slice kept from each sale thins out, so does the profit.
On our five-subject report card, MBAI sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: MBAI is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.